4//SEC Filing
Collins Cooper C. 4
Accession 0001209191-21-066002
CIK 0000025743other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:30 AM ET
Size
5.2 KB
Accession
0001209191-21-066002
Insider Transaction Report
Form 4
Collins Cooper C.
Director
Transactions
- Purchase
Common Stock
2021-11-18$0.58/sh+1,000,000$578,500→ 2,236,864 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.5581 to $0.5850 for an average weighted purchase price of $0.5785. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001485508
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 6:30 AM ET
- Size
- 5.2 KB